
197 - Sweet Deal of Updates in Diabetes Pharmacotherapy from the ADA 2026 Standards of Care
In this episode, we discuss the most important annual updates in the American Diabetes Association Guidelines, Standards of Care 2026, parti...
Radio and PodcastLive Radio & PodcastsOpening Radio and Podcast...

Radio and PodcastLive Radio & PodcastsFetching podcast shows and categories...
Radio and PodcastLive Radio & PodcastsFetching podcast episodes...

Educational podcast presented by the Rosalind Franklin University College of Pharmacy. This podcast is produced by our pharmacy faculty to supplement study material and provide relevant drug...

In this episode, we discuss the most important annual updates in the American Diabetes Association Guidelines, Standards of Care 2026, parti...

In this episode, we review key updates from the 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke, incl...

In this episode, we review the clinical presentation, diagnosis, and treatment of uncomplicated urinary tract infections. Key Concepts Uncom...

In this episode, we review the pharmacology, indications, adverse effects, and unique drug characteristics of 5-HT3 receptor antagonists suc...

In this episode, we review the newly published 2025 ACC/AHA hypertension guidelines. Key Concepts Instead of the Pooled Cohort Equations (PC...

In this episode, we discuss the evidence, safety, and place in therapy of Journavx® (suzetrigine), a newly approved analgesic with a unique...

In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of angiotensin recept...

In this episode, we discuss the diagnosis and treatment of resistant hypertension, including a newer endothelin receptor antagonist (ERA) ca...

In this episode, we discuss the very early stages of drug targets and drug development with Dr. Mohd Shahid, PhD. Dr. Shahid's research invo...

In this episode, we review the new 2025 ACC/AHA Acute Coronary Syndrome (ACS) guidelines, with a particular focus on guideline recommendatio...

In this episode, we interview Morgan Anderson, PharmD, BCIDP, a graduate of the RFUMS College of Pharmacy, about her career path from a phar...

In this episode, we discuss the efficacy and safety of semaglutide and tirzepatide for weight loss with a particular focus on the legal, reg...

In this episode, we review the recommendations from the 2024 SCCM/ASHP stress ulcer prophylaxis guidelines and highlight three of the more r...

In this episode, we discuss the approach to deprescribing for several drugs such as benzodiazepine receptor agonists, cholinesterase inhibit...

In this episode, we review the pharmacology, pharmacokinetics, adverse effects, monitoring, medicinal chemistry, and more of loop diuretics....

In this episode, we discuss principles for medication use in the geriatric patient population and summarize the updated 2023 American Geriat...

In this episode, we discuss artificial intelligence large language models (LLMs) and how these will impact the future of the practice of pha...

In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of HMG CoA reductase...

In this recurring episode, we discuss the important updates from the 2024 American Diabetes Association Guidelines! Key Concepts Tirzepatide...

In this episode, we speak with Janeen Winnike, the Associate Dean for Student Affairs at Rosalind Franklin and a co-course director for the...

In this episode, we review evidence-based guidelines for the emergency reversal of warfarin, dabigatran, and the oral Xa inhibitors (apixaba...

In this two part episode, we review some of the most important clinical pearls in the pharmacotherapy and practice aspects of hormonal contr...

In this two part episode, we review some of the most important clinical pearls in the pharmacotherapy and practice aspects of hormonal contr...

In this episode, we interview Scott Glosner, PharmD, MPH, BCPS about his extensive experience working at Pfizer in medical outcomes and as a...

In this episode, we will discuss the definition of REMS (Risk Evaluation and Mitigation Strategies), why they exist, the role of FDA in admi...

In this episode, we review the role and indications of thrombolytics in acute ischemic stroke. The efficacy, safety, administration consider...

In this episode, we briefly review RSV (respiratory syncytial virus) infections and focus on new data supporting the use of two different RS...

In this episode, together with our faculty colleague, Dr. Roberta Dume, PharmD, BCPP, we discuss the pharmacologic options and evidence for...

In this episode, we announce the second iteration of the HelixTalk Drug Superlative Awards -- awards given to medications on the market that...

There has been a lot of news about abortion (abortifacient) medications recently. Since the overturn of Roe v. Wade in 2022, individual stat...

In this episode, we review the science behind genetic differences in humans in the CYP2D6 hepatic enzyme responsible for drug metabolism and...

In this episode, we compare hydrochlorothiazide and chlorthalidone, but specifically from a cardiovascular outcomes perspective when used in...

In this episode, we discuss the concerns of QTc prolongation, which can cause a fatal arrhythmia called torsades de pointes (TdP). We cover...

In this episode, we will discuss the most important updates from the American Diabetes Association's 2023 Standards of Care in Diabetes. Key...

In this episode, we review clinical pearls and common pitfalls of immunosuppression regimens for organ transplantation with a particular foc...

In this first ever CE episode, we discuss the A-Zs of continuous glucose monitors (CGMs). In specific, our learning objective for the CE are...

In this episode, we interview Dr. Shannon Rotolo and Dr. Alex Berce regarding Illinois and Wisconsin drug repository programs – these are pr...

In this episode, we discuss the evidence, safety, and place in therapy of Auvelity® (dextromethorphan-bupropion), a newly approved antidepre...

In this episode, we highlight important changes to the 2023 GOLD Guidelines for COPD. In particular, we discuss a revision to the GOLD group...

In this episode, we will discuss all things peripheral arterial disease – definitions, staging, clinical presentation, risk factors, goals o...

In this episode, we review the management of a patient with hypokalemia, including both inpatient and outpatient supplementation with potass...

In this episode, we will define Digital Health, its categories and examples, describe how pharmacists are involved in DH practice, opportuni...

In this episode, we invite Dr. Amir Ali, PharmD, BCOP to discuss with us the pathophysiology, risk factors, prevention, and treatment clinic...

In this episode, we review Paxlovid (nirmatrelvir/ritonavir) from the perspective of its pharmacology, efficacy, safety, pharmacists' author...

In this episode, we will discuss mechanism, pharmacokinetics, efficacy, safety, and possible place in therapy for tirzepatide (Mounjaro), a...

In this episode, we will discuss the rationale behind the FDA approval of two new pneumococcal conjugate vaccines (PCV20 and PCV15), the cha...

In this episode, we "deep dive" into diltiazem, describing its most important drug facts, pharmacology and medicinal chemistry, pharmaceutic...

In this episode, the hosts of the HelixTalk reflect back on the history and making of HelixTalk to commemorate the 150th episode. We review...

In this episode, we will cover a complete overview of definition, diagnosis, treatment and monitoring of iron deficiency anemia (IDA). Key C...

In this episode, we interview Hetal Patel, PharmD and RFUMS COP Alumni, regarding her career path that eventually led her to open Lebanon Fa...